Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Interventional × S-Adenosylmethionine × Clear all

Phase

Status

Unknown 2 Terminated 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Cyclophosphamide 343 Carboplatin 290 pembrolizumab 272 Gemcitabine 271 Cisplatin 267 Radiotherapy 256 Paclitaxel 251 Docetaxel 249 Bevacizumab 213 Rituximab 201 Capecitabine 192 Nivolumab 181 Dexamethasone 174 Fluorouracil 170 fludarabine 157 Oxaliplatin 150 Doxorubicin 136 Leucovorin 127 Irinotecan 127 Pemetrexed 124 Etoposide 124 Cytarabine 122 fludarabine phosphate 112 Bortezomib 111 Lenalidomide 108 Filgrastim 106 Cetuximab 104 Erlotinib Hydrochloride 100 Temozolomide 95 Trastuzumab 92

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03721679 2021-02-01

Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1

Oncovir, Inc.

Phase 1/2 Terminated

Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡